1. Home
  2. AEI vs BHST Comparison

AEI vs BHST Comparison

Compare AEI & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alset Inc. (TX)

AEI

Alset Inc. (TX)

HOLD

Current Price

$1.75

Market Cap

119.4M

Sector

Real Estate

ML Signal

HOLD

Logo BioHarvest Sciences Inc.

BHST

BioHarvest Sciences Inc.

N/A

Current Price

$4.27

Market Cap

97.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AEI
BHST
Founded
2014
2007
Country
United States
Canada
Employees
N/A
87
Industry
Building operators
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
119.4M
97.7M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
AEI
BHST
Price
$1.75
$4.27
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
16.3K
26.9K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,238,200.00
N/A
Revenue This Year
N/A
$146.27
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$4.10
52 Week High
$4.55
$12.80

Technical Indicators

Market Signals
Indicator
AEI
BHST
Relative Strength Index (RSI) 45.26 44.99
Support Level $1.47 $4.27
Resistance Level $2.11 $5.02
Average True Range (ATR) 0.16 0.13
MACD 0.02 0.01
Stochastic Oscillator 36.00 12.50

Price Performance

Historical Comparison
AEI
BHST

About AEI Alset Inc. (TX)

Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: